Skip to main content

Advertisement

SpringerLink
Log in

Green tea consumption and breast cancer risk or recurrence: a meta-analysis

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Green tea is a commonly consumed beverage in Asia and has been suggested to have anti-inflammatory and possible anti-carcinogenic properties in laboratory studies. We sought to examine the association between green tea consumption and risk of breast cancer incidence or recurrence, using all available epidemiologic evidence to date. We conducted a systematic search of five databases and performed a meta-analysis of studies of breast cancer risk and recurrence published between 1998 and 2009, encompassing 5,617 cases of breast cancer. Summary relative risks (RR) were calculated using a fixed effects model, and tests of heterogeneity across combined studies were conducted. We identified two studies of breast cancer recurrence and seven studies of breast cancer incidence. Increased green tea consumption (more than three cups a day) was inversely associated with breast cancer recurrence (Pooled RR = 0.73, 95% CI: 0.56–0.96). An analysis of case–control studies of breast cancer incidence suggested an inverse association with a pooled RR of 0.81 (95% CI: 0.75, 0.88) while no association was found among cohort studies of breast cancer incidence. Combining all studies of breast cancer incidence resulted in significant heterogeneity. Available epidemiologic evidence supports the hypothesis that increased green tea consumption may be inversely associated with risk of breast cancer recurrence. The association between green tea consumption and breast cancer incidence remains unclear based on the current evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ries LAG, Melbert D, Krapcho M et al (eds) (2008) SEER Cancer Statistics Review, 1975–2005, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site

  2. Parkin DM, Ferlay J, Hamdi-Cherif M et al (2003) Cancer in Africa—epidemiology and prevention. IARC Scientific Publications No 153, Lyon

  3. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. version 2.0. IARC Press, Lyon

    Google Scholar 

  4. Alberg AJ, Helzlsouer KJ (1997) Epidemiology, prevention, and early detection of breast cancer. Curr Opin Oncol 9(6):505–511. doi:10.1097/00001622-199711000-00003

    Article  CAS  PubMed  Google Scholar 

  5. Yang CS, Chung JY, Yang G, Chhabra SK, Lee MJ (2000) Tea and tea polyphenols in cancer prevention. J Nutr 130:472S–478S

    CAS  PubMed  Google Scholar 

  6. Gupta S, Hussain T, Mukhtar H (2003) Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410:177–185. doi:10.1016/S0003-9861(02)00668-9

    Article  CAS  PubMed  Google Scholar 

  7. Sartippour MR, Heber D, Ma J et al (2001) Green tea and its catechins inhibit breast cancer xenografts. Nutr Cancer 40:149–156. doi:10.1207/S15327914NC402_11

    Article  CAS  PubMed  Google Scholar 

  8. Kemberling JK, Hampton JA, Keck RW, Gomez MA, Selman SH (2003) Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate. J Urol 170:773–776. doi:10.1097/01.ju.0000081278.64511.96

    Article  CAS  PubMed  Google Scholar 

  9. Landis-Piwowar KR, Huo C, Chen D et al (2007) A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Cancer Res 67(9):4303–4310. doi:10.1158/0008-5472.CAN-06-4699

    Article  CAS  PubMed  Google Scholar 

  10. Shimizu M, Fukutomi Y, Ninomiya M et al (2008) Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev 17(11):3020–3025. doi:10.1158/1055-9965.EPI-08-0528

    Article  CAS  PubMed  Google Scholar 

  11. Eddy SF, Kane SE, Sonenshein GE (2007) Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. Cancer Res 67(19):9018–9023. doi:10.1158/0008-5472.CAN-07-1691

    Article  CAS  PubMed  Google Scholar 

  12. Kavanagh KT, Hafer LJ, Kim DW et al (2001) Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem 82:387–398. doi:10.1002/jcb.1164

    Article  CAS  PubMed  Google Scholar 

  13. Mnich CD, Hoek KS, Virkki LV, Farkas A, Dudli C, Laine E, Urosevic M, Dummer R (2009) Green tea extract reduces induction of p53 and apoptosis in UVB-irradiated human skin independent of transcriptional controls. Exp Dermatol 18(1):69–77. doi:10.1111/j.1600-0625.2008.00765.x

    Article  CAS  PubMed  Google Scholar 

  14. Kim J, Zhang X, Rieger-Christ KM et al (2006) Suppression of Wnt signaling by the green tea compound (_)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells: Requirement of the transcriptional repressor HBP1. J Biol Chem 281:10865–10875. doi:10.1074/jbc.M513378200

    Article  CAS  PubMed  Google Scholar 

  15. Feng WY (2006) Metabolism of green tea catechins: an overview. Curr Drug Metab 7:755–809. doi:10.2174/138920006778520552

    Article  CAS  PubMed  Google Scholar 

  16. Yamakawa S, Asai T, Uchida T et al (2004) (_)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Lett 210:47–55. doi:10.1016/j.canlet.2004.03.008

    Article  CAS  PubMed  Google Scholar 

  17. Kao YH, Hiipakka RA, Liao S (2000) Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141(3):980–987. doi:10.1210/en.141.3.980

    Article  CAS  PubMed  Google Scholar 

  18. Lam WH, Kazi A, Kuhn DJ et al (2004) A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (_)-epigallocatechingallate. Bioorg Med Chem 12:5587–5593. doi:10.1016/j.bmc.2004.08.002 (_)-EGCG

    Article  CAS  PubMed  Google Scholar 

  19. Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y (1998) Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 89:254–261

    CAS  PubMed  Google Scholar 

  20. Inoue M, Tajima K, Mizutani M et al (2001) Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett 167:175–182. doi:10.1016/S0304-3835(01)00486-4

    Article  CAS  PubMed  Google Scholar 

  21. Key TJ, Sharp GB, Appleby PN et al (1999) Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer 81:1248–1256. doi:10.1038/sj.bjc.6690837

    Article  CAS  PubMed  Google Scholar 

  22. Suzuki Y, Tsubono Y, Nakaya N, Koizumi Y, Tsuji I (2004) Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer 90:1361–1363. doi:10.1038/sj.bjc.6601652

    Article  CAS  PubMed  Google Scholar 

  23. Tao M, Liu D, Gao L, Jin F (2002) Association between green tea drinking and breast cancer risk. Tumor 22(3):11–15 (in Chinese)

    Google Scholar 

  24. Inoue M, Robien K, Wang R, van den Berg D, Koh WP, Yu MC (2008) Green tea intake, MTHFR/TYMS genotype, and breast cancer risk: The Singapore Chinese Health Study. Carcinogenesis 29(10):1967–1972. doi:10.1093/carcin/bgn177

    Article  CAS  PubMed  Google Scholar 

  25. Shrubsole MJ, Lu W, Chen Z et al (2009) Drinking green tea modestly reduces breast cancer risk. J Nutr 139:1–7

    Google Scholar 

  26. Wu AH, Yu MC, Tseng CC, Hankin J, Pike MC (2003) Green tea and risk of breast cancer in Asian Americans. Int J Cancer 106:574–579. doi:10.1002/ijc.11259

    Article  CAS  PubMed  Google Scholar 

  27. Zhang M, Holman CD, Huang JP, Xie X (2007) Green tea and the prevention of breast cancer: a case–control study in Southeast China. Carcinogenesis 28(5):1074–1078. doi:10.1093/carcin/bgl252

    Article  CAS  PubMed  Google Scholar 

  28. Wu AH, Tseng CC, Van Den Berg D, Yu MC (2003) Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res 63:7526–7529

    CAS  PubMed  Google Scholar 

  29. Yuan JM, Koh WP, Sun CL, Lee HP, Yu MC (2005) Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis 26(8):1389–1394. doi:10.1093/carcin/bgi080

    Article  CAS  PubMed  Google Scholar 

  30. Nagano J, Kono S, Preston DL, Mabuchi K (2001) A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control 12:501–508. doi:10.1023/A:1011297326696

    Article  CAS  PubMed  Google Scholar 

  31. Seely D, Mills EJ, Wu P, Verma S, Guyatt GH (2005) The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr Cancer Ther 4(2):144–155. doi:10.1177/1534735405276420

    Article  PubMed  Google Scholar 

  32. Satoh K, Sakamoto Y, Ogata A et al (2002) Inhibition of aromatase activity by green tea extract, catechins and their endocrinological effects of oral administration in rats. Food Chem Toxicol 40:925–933. doi:10.1016/S0278-6915(02)00066-2

    Article  CAS  PubMed  Google Scholar 

  33. McLarty J, Bigelow R, Williams B et al (2007) Prostate cancer patients administered green tea polyphenols demonstrate a reduction in serum levels of HGF and VEGF, and tissue levels of phosphorylated c-Met and phosphorylated Akt. In: Proceedings of the 98th Annual Meeting of the American Association of Cancer Research, Los Angeles, CA, 14–17 Apr, AACR, 2007, Abstract nr 2657

Download references

Sources of support

Dr. Ogunleye is an Ekiti State of Nigeria Postgraduate Scholarship awardee.

Author information

Authors and Affiliations

  1. Department of Epidemiology, Harvard School of Public Health, 677, Huntington Avenue, Boston, MA, USA

    Adeyemi A. Ogunleye & Karin B. Michels

  2. Amgen Inc., Global Safety, One Amgen Center Drive, MS 17-1-A, Thousand Oaks, CA, USA

    Fei Xue

  3. Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Karin B. Michels

Authors
  1. Adeyemi A. Ogunleye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fei Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karin B. Michels
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adeyemi A. Ogunleye.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ogunleye, A.A., Xue, F. & Michels, K.B. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat 119, 477–484 (2010). https://doi.org/10.1007/s10549-009-0415-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-009-0415-0

Keywords

Search

Navigation